Dr. Katrina S. Pedersen
Claim this profileWashington University School of Medicine
Studies Colorectal Cancer
Studies Stomach Cancer
21 reported clinical trials
45 drugs studied
About Katrina S. Pedersen
Education:
- Obtained MD from Washington University School of Medicine in 2015.
Experience:
- Completed Residency in Internal Medicine at Barnes-Jewish Hospital, Washington University School of Medicine (2015-2018).
- Undertook Fellowship in Hematology and Oncology at Washington University School of Medicine (2018-2021).
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
dMMR negative
2Stomach Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Katrina S. Pedersen is currently running
Combination Chemotherapy
for Biliary Tract Cancer
This trial is testing a new combination of three drugs for patients with advanced biliary tract cancers who did not respond well to their first treatment. The drugs work together to damage the cancer cells' DNA and stop them from growing. The goal is to find a better second-line treatment for these patients. Previous tests with similar drugs did not show improvement.
Recruiting1 award Phase 29 criteria
Cabozantinib
for Neuroendocrine Cancer
High grade neuroendocrine neoplasm patients are treated with platinum doublets such as carboplatin and etoposide mimicking the current guidelines for small cell lung cancer (SCLC). Unfortunately, recurrences are common and most patients with metastatic disease succumb to it within a year. There is no extensive literature or consensus on second- or third-line options (which include FOLFOX, FOLFIRI, capecitabine and temozolomide, taxanes or immunotherapy) and there is urgent need for better regimens.
Recruiting1 award Phase 2
More about Katrina S. Pedersen
Clinical Trial Related7 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Katrina S. Pedersen has experience with
- Fluorouracil
- Leucovorin
- Bevacizumab
- Leucovorin Calcium
- Irinotecan
- Irinotecan Hydrochloride
Breakdown of trials Katrina S. Pedersen has run
Colorectal Cancer
Stomach Cancer
Rectal Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katrina S. Pedersen specialize in?
Katrina S. Pedersen focuses on Colorectal Cancer and Stomach Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Katrina S. Pedersen currently recruiting for clinical trials?
Yes, Katrina S. Pedersen is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Katrina S. Pedersen has studied deeply?
Yes, Katrina S. Pedersen has studied treatments such as Fluorouracil, Leucovorin, Bevacizumab.
What is the best way to schedule an appointment with Katrina S. Pedersen?
Apply for one of the trials that Katrina S. Pedersen is conducting.
What is the office address of Katrina S. Pedersen?
The office of Katrina S. Pedersen is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.